BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Kate Carr To Lead Accelerate Brain Cancer Cure As President And CEO


1/10/2006 11:42:33 AM

WASHINGTON, and SAN FRANCISCO, Jan. 10 /PRNewswire/ -- Accelerate Brain Cancer Cure (ABC2) announced today that Kate Carr, former President and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, has been named President and CEO of ABC2, effective immediately. Ms. Carr replaces John Reher, who will soon be launching a venture capital firm that will focus on investing in innovative companies developing treatments for a range of brain diseases.

Steve Case, Chairman and CEO of Revolution and Chairman of ABC2, will include an update on ABC2's progress as part of the "Revolutionizing Health" keynote speech he is delivering at the JPMorgan Healthcare Conference, now underway in San Francisco. Case will be speaking at 12:00 noon (Pacific time) on Tuesday, January 10, in the Grand Ballroom at the Westin St. Francis Hotel.

"Under John's leadership, ABC2 has brought an entrepreneurial spirit and approach to cancer research, the success of which can be measured by the number of potential new therapies the organization has helped advance into clinical development," Mr. Case said. "We are thrilled to have a new leader of Kate's caliber at ABC2. Her passion for our mission and her experience building partnerships as an advocate in the nonprofit and government sectors will be invaluable as we intensify our efforts to hasten a cure for brain cancer. Her track record building the Elizabeth Glaser Pediatric AIDS Foundation makes her the perfect leader for ABC2 as we prepare to expand."

Ms. Carr said, "Brain cancer is one of the last great challenges in cancer research. Leading ABC2 is a tremendous opportunity to collaborate with the best and brightest minds in the field -- including researchers at academic medical centers, NIH, FDA, and industry."

Ms. Carr brings a wealth of experience in politics, government, and public-private partnerships. Before serving at the Elizabeth Glaser Pediatric AIDS Foundation for seven years, she was chief operating officer for the Welfare to Work Partnership and a special assistant to the president in the Clinton White House, overseeing outreach and partnerships with the business community.

ABC2 (http://www.abc2.org) was founded May 2001 by Dan and Steve Case and their families, along with leading scientists and entrepreneurs. In order to accelerate progress in what has been an underserved field of research, ABC2 applies a unique approach that provides researchers from all backgrounds with the support they need to make critical breakthroughs in brain cancer research. ABC2 aims to raise awareness about brain cancer and help mobilize critical scientific research through research grants and partnerships.

ABC2

CONTACT: Mark Miller, +1-202-467-2055, MMiller2080@aol.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES